These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3905843)

  • 1. [Preparation of monoclonal antibody to streptococcal nephritis-strain associated protein].
    Takasaki H
    Nihon Ika Daigaku Zasshi; 1985 Oct; 52(5):530-6. PubMed ID: 3905843
    [No Abstract]   [Full Text] [Related]  

  • 2. Demonstration of streptococcal antigens produced in vivo and identification of a nephritis associated protein.
    Bergholm AM; Holm SE
    Acta Pathol Microbiol Immunol Scand B; 1985 Aug; 93(4):297-306. PubMed ID: 3901668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of nephritis strain-associated protein (NSAP) in the extracellular product of Streptococcus pyogenes strain Su.
    Ohkuni H; Todome Y; Yamamoto A; Usami H; Tada S; Yokomuro K; Sugawara Y
    J Clin Lab Immunol; 1987 Aug; 23(4):209-12. PubMed ID: 3118039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of capsule enables Streptococcus pyogenes to evade immune recognition by antigen-specific antibodies directed to the G-related alpha2-macroglobulin-binding protein GRAB located on the bacterial surface.
    Dinkla K; Sastalla I; Godehardt AW; Janze N; Chhatwal GS; Rohde M; Medina E
    Microbes Infect; 2007 Jul; 9(8):922-31. PubMed ID: 17544803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Persistence of Streptococcus pyogenes].
    Dmitrieva NF; Timofeev IuM; Briko NI
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (3):104-9. PubMed ID: 19621829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of group A streptococci in mice and efficacy of locally administered streptococcal vaccines.
    Bronze MS; McKinsey DS; Beachey EH; Dale JB
    Trans Assoc Am Physicians; 1988; 101():88-92. PubMed ID: 3077732
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serological diagnosis of streptococcal infection (ASO, ASK, ADN-B, ASP)].
    Nakayama T
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():135-7. PubMed ID: 20942021
    [No Abstract]   [Full Text] [Related]  

  • 8. Human polyspecific immunoglobulin attenuates group A streptococcal virulence factor activity and reduces disease severity in a murine necrotizing fasciitis model.
    Tarnutzer A; Andreoni F; Keller N; Zürcher C; Norrby-Teglund A; Schüpbach RA; Zinkernagel AS
    Clin Microbiol Infect; 2019 Apr; 25(4):512.e7-512.e13. PubMed ID: 30025835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response to group A streptococci in an epidemic of streptococcal pharyngitis.
    Rabinowitz K; Bergner-Rabinowitz S; Ferne M; Fleiderman S; Beck A
    J Lab Clin Med; 1977 Sep; 90(3):466-74. PubMed ID: 330784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of the classical Lancefield assay of group A streptococcal killing to reduce inter-donor variation.
    Reglinski M; Lynskey NN; Sriskandan S
    J Microbiol Methods; 2016 May; 124():69-71. PubMed ID: 27030640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superantigens and streptococcal toxic shock syndrome.
    Proft T; Sriskandan S; Yang L; Fraser JD
    Emerg Infect Dis; 2003 Oct; 9(10):1211-8. PubMed ID: 14609454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superantigens of group A streptococci (Streptococcus pyogenes). Distribution, induction of antibodies, and binding to human cell types.
    Wagner B; Gerlach D; Ozegowski JH; Wagner M
    Adv Exp Med Biol; 1997; 418():555-7. PubMed ID: 9331712
    [No Abstract]   [Full Text] [Related]  

  • 13. Group A streptococci: pathogenesis and immunity.
    Maxted WR
    Soc Appl Bacteriol Symp Ser; 1978; 7():107-25. PubMed ID: 364656
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibacterial activity of the contact and complement systems is blocked by SIC, a protein secreted by Streptococcus pyogenes.
    Frick IM; Shannon O; Åkesson P; Mörgelin M; Collin M; Schmidtchen A; Björck L
    J Biol Chem; 2011 Jan; 286(2):1331-40. PubMed ID: 21068386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on streptococcal prevalence in Chiang Mai, Thailand, with special reference to unusual combination between T and M antigens of group A Streptococcus].
    Murai T; Inazumi Y; Pruksakorn S
    Kansenshogaku Zasshi; 1988 Oct; 62(10):869-77. PubMed ID: 3145307
    [No Abstract]   [Full Text] [Related]  

  • 16. [Streptococcus pyogenes--pathogenetic factors and their involvement in the pathogenesis of acute streptococcal infections and their complications].
    Ungureanu V
    Bacteriol Virusol Parazitol Epidemiol; 1993; 38(3-4):34-47. PubMed ID: 8173211
    [No Abstract]   [Full Text] [Related]  

  • 17. Binding of C1q to group A streptococcal M-family proteins.
    Koroleva IV; Schalen C; Sjoholm A
    Adv Exp Med Biol; 1997; 418():581-3. PubMed ID: 9331718
    [No Abstract]   [Full Text] [Related]  

  • 18. [The persistence and biodegradation of the cell walls of Streptococcus group A in light of the immunopathogenesis of nonsuppurative poststreptococcal diseases].
    Shikhman AR; Cherniakova AM; Briko NI
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Feb; (2):74-80. PubMed ID: 2188468
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current views of the etiology and pathogenesis of rheumatism. The role of streptococcal infection].
    Kutsyk RV; Dziubak ST; Neĭko EM
    Revmatologiia (Mosk); 1991; (4):25-9. PubMed ID: 1805328
    [No Abstract]   [Full Text] [Related]  

  • 20. Current status of group A streptococcal vaccine development.
    Dale JB
    Adv Exp Med Biol; 2008; 609():53-63. PubMed ID: 18193657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.